10 Chapter 27 Chapter 28 Chapter 29 Chapter 30 Chapter 31 Appendices PART V: COVID-19 AND IBD Angiotensin-converting enzyme-2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19) Journal of Pathology 2020;251(3):228-248. Treatment of severe acute ulcerative colitis in SARS-CoV-2-infected patients: report of three cases and discussion of treatment options Therapeutic Advances in Gastroenterology 2021;14:17562848211012595. Mild coronavirus disease 2019 (COVID-19) is marked by systemic oxidative stress: a pilot study Antioxidants 2021;10(12):2022. Use of tumor necrosis factor-α antagonists is associated with attenuated IgG antibody response against SARS-CoV-2 in vaccinated patients with inflammatory bowel disease Frontiers in Immunology 2022;13:920333. DISCUSSION Discussion, conclusions and future perspectives English summary Nederlandse samenvatting Curriculum vitae List of publications Dankwoord | Acknowledgements 887 889 929 947 969 995 997 1047 1049 1057 1067 1071 1085
RkJQdWJsaXNoZXIy MjY0ODMw